TY  - GEN
AU  - Merkesdal,Sonja
AU  - Kirchhoff,Timm
AU  - Wolka,Diane
AU  - Ladinek,Gunter
AU  - Kielhorn,Adrian
AU  - Rubbert-Roth,Andrea
TI  - Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure
SN  - 1618-7601
PY  - 2011///0106
KW  - Aged
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - economics
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - drug therapy
KW  - Cost-Benefit Analysis
KW  - Etanercept
KW  - Female
KW  - Germany
KW  - Humans
KW  - Immunoglobulin G
KW  - Immunosuppressive Agents
KW  - Male
KW  - Markov Chains
KW  - Middle Aged
KW  - Models, Econometric
KW  - Probability
KW  - Quality-Adjusted Life Years
KW  - Receptors, Tumor Necrosis Factor
KW  - therapeutic use
KW  - Rituximab
KW  - Surveys and Questionnaires
KW  - Treatment Failure
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s10198-009-0205-y
ER  -